Changes in myocardial lactate, pyruvate and lactate-pyruvate ratio during cardiopulmonary bypass for elective adult cardiac surgery: Early indicator of morbidity

Pm Kapoor, B Mandal, Uk Chowdhury, Sp Singh, U Kiran, Pm Kapoor, B Mandal, Uk Chowdhury, Sp Singh, U Kiran

Abstract

Background: Myocardial lactate assays have been established as a standard method to compare various myocardial protection strategies. This study was designed to test whether coronary sinus (CS) lactates, pyruvate and lactate-pyruvate (LP) ratio correlates with myocardial dysfunction and predict postoperative outcomes.

Materials and methods: This prospective observational study was conducted on 40 adult patients undergoing elective cardiac surgery with the aid of cardiopulmonary bypass (CPB). CS blood sampling was done for estimation of myocardial lactate (ML), pyruvate (MP) and lactate-pyruvate ratio (MLPR) namely: pre-CPB (T(1)), after removal of aortic cross clamp (T(2)) and 30 minutes post-CPB (T(3)).

Results: Baseline myocardial LPR strongly correlated with Troponin-I at T1 (σ: 0.6). Patients were sub grouped according to the median value of myocardial lactate (2.9) at baseline T1 into low myocardial lactate (LML) group, mean (2.39±0.4 mmol/l), n=19 and a high myocardial lactate (HML) group, mean (3.65±0.9 mmol/l), n = 21. A significant increase in PL, ML, MLPR and TropI occurred in both groups as compared to baseline. Patients in HML group had significant longer period of ICU stay. Patients with higher inotrope score had significantly higher ML (T2, T3). ML with a baseline value of 2.9 mmol/l had 70.83% sensitivity and 62.5% specificity (ROC area: 0.7109 Std error: 0.09) while myocardial pyruvate with a baseline value of 0.07 mmol/l has 79.17% sensitivity and 68.75% specificity (ROC area: 0.7852, Std error: 0.0765) for predicting inotrope requirement after CPB.

Conclusion: CS lactate, pyruvate and LP ratio correlate with myocardial function and can predict postoperative outcome.

Keywords: Coronary sinus; lactate; lactate-pyruvate ratio; pyruvate.

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Receiver operator characteristic curve showing sensitivity and (1-specificity) of precardiopulmonary bypass coronary sinus myocardial lactate and pyruvate for inotropic requirement after ca rdiopulmonary bypass. (a) ROC area: 0.7109 (ML); Std error: 0.09 (b) ROC area: 0.7852 (MP); Std error: 0.0765

References

    1. Baker S, Cadogan M. Varying clinical significance of hyperlactatemia. Critical Care Resusc. 2005;7:57–9.
    1. Raper RF, Cameron G, Walker D, Bowey JC. Type B lactic acidosis following cardiopulmonary bypass. Crit Care Med. 1997;25:46–51.
    1. Levy B, Sadoune LO, Gelot AM, Bollaert P, Nabet PG, Larcan A. Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock. Crit Care Med. 2000;28:114–9.
    1. Shinde S, Golam K, Patil N, Kumar P, Kesevan Perioperative blood lactate levels, pyruvate levels and lactate/pyruvate ratio in children undergoing cardiopulmonary bypass for congenital heart disease. Internet J Anaesthesiol. 2006;10:1–6.
    1. Bäckström T, Franco-Cereceda A. Intravasal microdialysis is superior to intramyocardial microdialysis in detecting local ischaemia in experimental porcine myocardial infarction. Acta Physiol Scand. 2004;180:5–12.
    1. Heringlake M, Bahlmann L, Misfeld M, Poeling J, Leptien A, Kraatz E, et al. High myocardial lactate concentration is associated poor myocardial function prior to cardiopulmonary bypass. Minerva Anestesiol. 2005;71:775–83.
    1. Mayer J, Boldt J, Wolf WM, Lang J, Suttner S. Cardiac output derived arterial pressure waveform analysis in patients undergoing cardiac surgery: Validity of a second generation device. Anesth Analg. 2008;106:867–72.
    1. Gundry SR, Sequiera A, Razzouk AM, McLaughlin JS, Bailey LL. Facile retrograde cardioplegia: transatrial cannulation of the coronary sinus. Ann Thorac Surg. 1990;50:882–7.
    1. Onorati F, Cristodoro L, Caroleo S, Esposito A, Amantea B, Santangelo E, et al. Troponin I and lactate from coronary sinus predict cardiac complication after myocardial revascularisation. Ann Thorac Surg. 2007;83:1016–23.
    1. Crittenden MD. Intraoperative metabolic monitoring of the heart: Clinical assessment of coronary sinus metabolites. Ann Thorac Surg. 2001;72:S2220–6.
    1. Siouffi SY, Kwanik EM, Khuri SF. Methods for the metabolic quantification of regional myocardial ischemia. J Surg Res. 1987;43:360–78.
    1. Inoue S, Kuro M, Furuya H. What factors are associated with hyperlactatemia after cardiac surgery characterized by well-maintained oxygen delivery and a normal postoperative course? A retrospective study. Eur J Anaesthesiol. 2001;18:576–84.
    1. Shinde SB, Golam KK, Kumar P, Patil ND. Blood lactate levels during cardiopulmonary bypass for valvular heart surgery. Ann Card Anaesth. 2005;8:38–44.
    1. Duke T, Butt W, South M, Karl TR. Early markers of major adverse events in children after cardiac operation. J Thorac Cardiovasc Surg. 1997;114:1042–52.
    1. Andersen LW, Landow L, Baek L, Jansen E, Baker S. Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor – α concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med. 1993;21:210–7.
    1. Hatherill M, Sajjanhar T, Tibby SM, Champion MP, Andersopn D, Marsh MJ, et al. Serum lactate as a predictor of mortality after paediatric cardiac surgery. Arch Dis Child. 1997;77:235–8.
    1. Raman JS, Bellomo R, Hayhoe M, Tsamitros M, Buxton BF. Metabolic changes and myocardial injury during cardioplegia: A pilot study. Ann Thorac Surg. 2001;72:1566–71.
    1. Koh TW, Carr-White GS, DeSouza AC, Ferdinand FD, Hooper J, Kemp M, et al. Intraoperative cardiac Troponin T release and lactate metabolism during coronary artery surgery: Comparision of beating heart with conventional coronary artery surgery with cardiopulmonary bypass. Heart. 1999;81:495–500.
    1. Rao V, Ivanov J, Weisel RD, Cohen G, Borger MA, Mickle DA. Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery. Ann Thorac Surg. 2001;71:1925–30.
    1. Wikstrom BG, Ronquist G, Waldenstrom A. Dynamics of myocardial metabolism in the preconditioned porcine heart studied using continuous microdialysis. Eur Heart J. 1995;16:563–9.
    1. Cross HR, Clarke K, Opie LH, Radda GK. Is lactate-induced myocardial ischemia injury mediated by decreased pH or increased intracellular lactate? J Mol Cell Cardiol. 1995;27:1369–81.
    1. Metzsch C, Liao Q, Steen S, Algotsson L. Myocardial glycerol release, arrhythmias and hemodynamic instability during regional ischemia-reperfusion in an open chest pig model. Acta Anaesthesiol Scand. 2006;50:99–107.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다